{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:51:10Z","timestamp":1787503870776,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H06279"],"award-info":[{"award-number":["16H06279"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["Y118"],"award-info":[{"award-number":["Y118"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.mcpro.2024.100870","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T02:53:51Z","timestamp":1729824831000},"page":"100870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-5970","authenticated-orcid":false,"given":"Kohei","family":"Kume","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yashima-Abo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-9898","authenticated-orcid":false,"given":"Hayato","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wulfkuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5080-5972","authenticated-orcid":false,"given":"Virginia","family":"Espina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-0570","authenticated-orcid":false,"given":"Doris R.","family":"Siwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Emanuel","family":"Petricoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance A.","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-9614","authenticated-orcid":false,"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-790X","authenticated-orcid":false,"given":"Satoshi S.","family":"Nishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2024.100870_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study","volume":"4","author":"Global Burden of Disease Cancer Collaboration","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jamasurg.2013.3959","article-title":"Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND\/UCLA expert panel","volume":"149","author":"Brar","year":"2014","journal-title":"JAMA Surg."},{"key":"10.1016\/j.mcpro.2024.100870_bib3","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.1998.16.8.2877","article-title":"Uracil-tegafur in gastric carcinoma: a comprehensive review","volume":"16","author":"Takiuchi","year":"1998","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mcpro.2024.100870_bib5","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Uesaka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mcpro.2024.100870_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls","volume":"8","author":"Baud","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mcpro.2024.100870_bib8","first-page":"4136","article-title":"Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue","volume":"7","author":"Sasaki","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib9","first-page":"1071","article-title":"Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma","volume":"24","author":"Yamanaka","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043236","article-title":"Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers","volume":"7","author":"Ishida","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2024.100870_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS-STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mcpro.2024.100870_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10120-018-0881-3","article-title":"The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells","volume":"22","author":"Mori","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.mcpro.2024.100870_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s43188-020-00044-3","article-title":"Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells","volume":"37","author":"Choi","year":"2021","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ddr.21650","article-title":"Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK\/mTOR pathway","volume":"81","author":"Xiao","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10120-013-0249-7","article-title":"Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase","volume":"17","author":"Nakamura","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.mcpro.2024.100870_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.canlet.2007.01.006","article-title":"Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil","volume":"252","author":"Kodera","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mcpro.2024.100870_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2024.100870_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.mcpro.2024.100870_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090155","article-title":"A\u00a0compensatory role of NF-kappaB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines","volume":"9","author":"Endo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2024.100870_bib20","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/nprot.2008.179","article-title":"Reverse-phase protein lysate microarrays for cell signaling analysis","volume":"3","author":"Spurrier","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2024.100870_bib21","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/pmic.200700117","article-title":"Antibody screening database for protein kinetic modeling","volume":"7","author":"Spurrier","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2024.100870_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2105-7-192","article-title":"AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies","volume":"7","author":"Major","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.mcpro.2024.100870_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jso.24977","article-title":"Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy","volume":"117","author":"Nishizuka","year":"2018","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jso.25718","article-title":"Recurrence risk evaluation in T1N1M0\/T2N0M0\/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms","volume":"120","author":"Ohmori","year":"2019","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/jnci\/djac085","article-title":"Helicobacter pylori modulated host immunity in gastric cancer patients with S-1 adjuvant chemotherapy","volume":"114","author":"Koizumi","year":"2022","journal-title":"J\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.mcpro.2024.100870_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil","volume":"145","author":"Lei","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcpro.2024.100870_bib27","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1101\/gad.1955310","article-title":"Expanded roles of the Fanconi anemia pathway in preserving genomic stability","volume":"24","author":"Kee","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.mcpro.2024.100870_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2024.100870_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbamcr.2012.12.002","article-title":"Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression","volume":"1833","author":"Jiang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcpro.2024.100870_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mcpro.2024.100870_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcpro.2024.100870_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2024.100870_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.cdd.4401160","article-title":"Many cuts to ruin: a comprehensive update of caspase substrates","volume":"10","author":"Fischer","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mcpro.2024.100870_bib34","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1074\/jbc.M408585200","article-title":"Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis","volume":"280","author":"Sohn","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2024.100870_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.cdd.4401065","article-title":"Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain","volume":"9","author":"Cowling","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mcpro.2024.100870_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2024.100870_bib37","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-12-3858","article-title":"Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in\u00a0vitro measurement of enzyme activity","volume":"73","author":"Offer","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib38","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1111\/bcp.14742","article-title":"Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: implication for 5-fluorouracil toxicity","volume":"87","author":"Hamzic","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.mcpro.2024.100870_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1478-811X-7-9","article-title":"The roles of ASK family proteins in stress responses and diseases","volume":"7","author":"Hattori","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.mcpro.2024.100870_bib40","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/bcr3164","article-title":"RAC1 GTPase plays an important role in gamma-irradiation induced G2\/M checkpoint activation","volume":"14","author":"Yan","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200212141","article-title":"PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation","volume":"162","author":"Slack-Davis","year":"2003","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.mcpro.2024.100870_bib42","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1074\/jbc.M110000200","article-title":"Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1","volume":"277","author":"Zang","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2024.100870_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2010.06.017","article-title":"The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets","volume":"39","author":"Krishnakumar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2024.100870_bib44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3892\/or.2017.5399","article-title":"The JAK\/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines","volume":"37","author":"Doi","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mcpro.2024.100870_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.mcpro.2024.100870_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00595-019-01896-5","article-title":"Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives","volume":"50","author":"Tokunaga","year":"2020","journal-title":"Surg. Today"},{"key":"10.1016\/j.mcpro.2024.100870_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-020-2391-6","article-title":"Helicobacter pylori-induced adrenomedullin modulates IFN-gamma-producing T-cell responses and contributes to gastritis","volume":"11","author":"Kong","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcpro.2024.100870_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001125","article-title":"Anti-Helicobacter pylori antibody status is associated with cancer mortality: a longitudinal analysis from the Japanese DAIKO prospective cohort study","volume":"3","author":"Nishizuka","year":"2023","journal-title":"PLOS Glob. Public Health"},{"key":"10.1016\/j.mcpro.2024.100870_bib49","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.mcpro.2024.100870_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.mcpro.2024.100870_bib51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2018.05.024","article-title":"Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcpro.2024.100870_bib52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/1878-0261.13555","article-title":"Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer","volume":"18","author":"Bottger","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mcpro.2024.100870_bib53","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/s41467-023-38581-8","article-title":"ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer","volume":"14","author":"Wong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2024.100870_bib54","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1158\/1535-7163.MCT-16-0197","article-title":"Dual and specific inhibition of NAMPT and PAK4 By KPT-9274 decreases kidney cancer growth","volume":"15","author":"Abu Aboud","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mcpro.2024.100870_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13046-021-02005-6","article-title":"PARP inhibitors in gastric cancer: beacon of hope","volume":"40","author":"Wang","year":"2021","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112258118","article-title":"PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage","volume":"118","author":"Cheon","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2024.100870_bib57","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/1078-0432.CCR-04-1282","article-title":"Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer","volume":"11","author":"Lee","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib58","first-page":"1255","article-title":"Interferon regulatory factor-1 suppresses DNA damage response and reverses chemotherapy resistance by downregulating the expression of RAD51 in gastric cancer","volume":"10","author":"Tan","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.mcpro.2024.100870_bib59","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/2159-8290.CD-23-0857","article-title":"Early immune remodeling steers clinical response to frontline chemoimmunotherapy in advanced gastric cancer","volume":"14","author":"An","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcpro.2024.100870_bib60","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947624001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947624001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:06:44Z","timestamp":1778818004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947624001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1535947624001609"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2024.100870","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2024.100870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100870"}}